FABP1 and metabolic dysfunction-associated steatotic liver disease: Cd36, Cidea, and Fabp1 are considered PPARA-dependent genes that are highly expressed under metabolic stress in liver and could be potential therapeutic targets for nonalcoholic fatty liver disease [29,30,31].